Clevidipine during heart surgery improves blood pressure control
...e initial results against three very commonly used therapies demonstrate a new potentially valuable alternative, which is very encouraging," said Solomon Aronson, M.D., of Duke University Medical Center and lead author of the study. "With a better understanding of how to effectively control blood pressure dur...Implant device effectively maintains heart function for transplant-listed patients
...re, cardiologists are continuously looking for new therapies that address short-term and/or long-term needs of ...ventions, including LVAD implantation and diuretic therapies to support left ventricular function in severely compromised cardiovascular patients. ACC.07 is the ...EVEREST data on use of tolvaptan published in JAMA and featured at ACC
...lly, treating physicians could choose conventional therapies for their patients, including diuretics, digoxin, ACE inhibitors, angiotensin II receptor blockers, aldosterone blockers, -blockers, nitrates, nesiritide and/or hydralazine. "EVEREST adds to the collection of data on tolvaptan and its potential uses...New blood thinner may work without bleeding risk
...act that this patient population requires advanced therapies and is difficult to treat." ...Nanoparticles can track cells deep within living organisms
... Adult stem cells are also under investigation in therapies that enhance new blood vessel growth to improve the blood supply to diabetic patients' limbs or to repair blood vessels after a heart attack or bypass surgery. Tracking nanoparticle-labeled cells used in such treatments by MRI imaging would allow phy...Drug/intervention combinations offer benefit in severe CVD
...Session offers new insight into the most effective therapies for patients with severe left ventricular dysfunct...en beneficial in assisting physicians in selecting therapies by visualizing a patient's heart metabolism. The PET and Recovery Following Revascularization (PARR...Energy supplement under study for Parkinson's disease
... develop dementia and behavior disorders. Todays therapies including the gold standard, a synthetic dopamine...udy will enroll patients who have been on standard therapies from 90 days to two years and follow them for five years. Half the enrollees will get creatine and h...Major discovery raises prospect of better patient care by improving platelet life span
...e are in a much stronger position to devise better therapies for the management of platelet-related diseases." Dr Kile added, "For fifty years doctors have speculated about what controls platelet life span. We now know the identity of the precise molecular switch responsible. The team is now actively pursuin...Inhibiting blood to save the brain
...ing MS symptoms. "Current strategies to develop therapies to fight MS primarily target T cells," said Katerina Akassoglou, Ph.D., assistant professor in UCSD's Department of Pharmacology, whose study was published in the March 19 issue of Journal of Experimental Medicine. "Blood proteins have been neglect...Therapeutic unshackles p53 and causes tumor regression
...ause tumors for many years, there are no effective therapies for the treatment of KSHV-induced tumors. Now, researchers from the University of Helsinki, Finland, have found that the small-molecule inhibitor Nutlin-3a has antitumor effects in a mouse xenograft model of PEL. In the study, which appears online ...HIV in late childhood and adolescence a growing problem
...er risk of death. We also know that antiretroviral therapies (ART) are less effective if started in patients with advanced disease." Dr Ferrand and Dr Corbett argue that there is a need for more services aimed at older children and adolescents to provide accessible and sympathetic HIV testing and treatment s...New project to analyze why Polycystic Ovary Syndrome and insulin resistance are so closely linked
...ndon, hope this will enable the development of new therapies which target this part of the pathway, to counter the insulin resistance and the fertility problems that PCOS can cause. Insulin is released from cells in the pancreas after eating and it signals insulin-sensitive tissues (such as fat and muscle) ...Should NICE evaluate complementary medicine?
...enefit, but this is all the more reason that these therapies should be rigorously evaluated, they argue. They believe that failure to evaluate complementary therapies also leads to health inequalities because of uneven access and missed opportunities. For example, as...Landmark schizophrenia treatment study reveals that medication alone is not always effective
...g to a limited extent, more intensive psychosocial therapies are needed for schizophrenia patients to make meaningful gains in work, at home and in the community....Breast cancer survivors experience long-term heart disease risk from radiotherapy
...s on the association between more modern radiation therapies and cardiovascular disease in breast cancer survivors have been inconclusive. Maartje Hooning, M.D., of the Netherlands Cancer Institute in Amsterdam, and colleagues compared radiation treatment options, looking for differences in heart disease inci...Most children in US hospitals receive medicines off-label
...hildren may have failed to respond to conventional therapies and may receive drugs off-label because they have no approved options," said Dr. Shah. The authors point out that, while physicians may sometimes have no alternatives to treating children with off-label medications, the practice is not risk-free. ...Outcomes for patients with hepatitis B who need liver transplants
...e to other etiologies for which safe and effective therapies that can improve or stabilize liver disease in those with decompensated cirrhosis are not available" the authors conclude. In an accompanying editorial, Myron Schwartz and colleagues from the Mount Sinai Liver Cancer Program at the Mount Sinai Sch...Erectile dysfunction drugs may trump nitroglycerin for heart protection
...ption of early reperfusion, there are no available therapies that are truly effective in protecting or repairing such damage clinically. Rakesh C. Kukreja, Ph.D., professor of medicine and Eric Lipman Chair of Cardiology at VCU, and colleagues compared nitroglycerin with two erectile dysfunction drugs -- Via...Addiction breakthrough may lead to new treatments
...ide important new leads in the search for improved therapies for attention deficit/hyperactivity disorder (ADHD) and compulsive brain disorders such as drug addiction and pathological gambling." Government reports estimate there are between 281,000 and 506,000 individuals addicted to Class A drugs (to includ......studys leading researcher. Whether targeted cancer therapies could improve the survival rate for RA patients remains a subject for further research....